» Articles » PMID: 27398049

The Canadian Biliary Atresia Registry: Improving the Care of Canadian Infants with Biliary Atresia

Overview
Specialty Pediatrics
Date 2016 Jul 12
PMID 27398049
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Biliary atresia is the most common cause of end-stage liver disease and liver cirrhosis in children, and the leading indication for liver transplantation in the paediatric population. There is no cure for biliary atresia; however, timely diagnosis and early infant age at surgical intervention using the Kasai portoenterostomy optimize the prognosis. Late referral is a significant problem in Canada and elsewhere. There is also a lack of standardized care practices among treating centres in this country. Biliary atresia registries currently exist across Europe, Asia and the United States. They have provided important evidence-based information to initiate changes to biliary atresia care in their countries with improvements in outcome. The Canadian Biliary Atresia Registry was initiated in 2013 for the purpose of identifying best standards of care, enhancing public education, facilitating knowledge translation and advocating for novel national public health policy programs to improve the outcomes of Canadian infants with biliary atresia.

Citing Articles

Primary antibiotic prophylaxis in biliary atresia did not demonstrate decreased infection rate: Multi-centre retrospective study.

Brody Y, Slae M, Amir A, Mozer-Glassberg Y, Bar-Lev M, Shteyer E Acta Paediatr. 2024; 114(3):654-659.

PMID: 39528247 PMC: 11828718. DOI: 10.1111/apa.17493.


Prognostic Factors Related to In-hospital Death in Children with Biliary Atresia: Analysis of a Nationwide Inpatient Database.

Shi Y, Jiang Y, Zhou G, Shi Y, Gan L, Kong Y J Clin Transl Hepatol. 2023; 11(2):416-424.

PMID: 36643040 PMC: 9817058. DOI: 10.14218/JCTH.2021.00456.


The Canadian Consortium for Research in Pediatric Surgery: Roadmap for Creation and Implementation of a National Subspecialty Research Consortium.

Emil S, Guadagno E, Baird R, Puligandla P, Romao R, Van HouWelingen L J Am Coll Surg. 2022; 235(6):952-961.

PMID: 36102499 PMC: 9653101. DOI: 10.1097/XCS.0000000000000396.


Portal plate bile duct diameter in biliary atresia is associated with long-term outcome.

Shpoliansky M, Tobar A, Mozer-Glassberg Y, Bar-Lev M, Shamir R, Shafir M Pediatr Surg Int. 2022; 38(6):825-831.

PMID: 35322291 DOI: 10.1007/s00383-022-05113-2.


Biliary Atresia - Too Few, Too Many Centers.

Amil Dias J GE Port J Gastroenterol. 2018; 25(2):57-58.

PMID: 29662927 PMC: 5892320. DOI: 10.1159/000484352.

References
1.
Shneider B, Brown M, Haber B, Whitington P, Schwarz K, Squires R . A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr. 2006; 148(4):467-474. DOI: 10.1016/j.jpeds.2005.12.054. View

2.
Lin Y, Chang M, Liao S, Wu J, Ni Y, Tiao M . Decreasing rate of biliary atresia in Taiwan: a survey, 2004-2009. Pediatrics. 2011; 128(3):e530-6. DOI: 10.1542/peds.2011-0742. View

3.
Schreiber R, Masucci L, Kaczorowski J, Collet J, Lutley P, Espinosa V . Home-based screening for biliary atresia using infant stool colour cards: a large-scale prospective cohort study and cost-effectiveness analysis. J Med Screen. 2014; 21(3):126-32. DOI: 10.1177/0969141314542115. View

4.
Schreiber R, Barker C, Roberts E, Martin S . Biliary atresia in Canada: the effect of centre caseload experience on outcome. J Pediatr Gastroenterol Nutr. 2010; 51(1):61-5. DOI: 10.1097/MPG.0b013e3181d67e5e. View

5.
Jones S, James E, Prasad S . Disease registries and outcomes research in children: focus on lysosomal storage disorders. Paediatr Drugs. 2010; 13(1):33-47. DOI: 10.2165/11586860-000000000-00000. View